A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers
Clinical trial NCT07364877 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07364877
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-28
- Primary completion
- 2026-03-19
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.